Shaofang Cai1, Xianming Rao2, Jianhong Ye2, Yuxiao Ling3, Shuai Mi3, Hanzhu Chen3, Chunhong Fan3, Yingjun Li4. 1. Department of Science and Education, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China. 2. The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China. 3. Department of Epidemiology and Health Statistics, Hangzhou Medical College School of Public Health, Hangzhou, China. 4. Department of Epidemiology and Health Statistics, Hangzhou Medical College School of Public Health, Hangzhou, China. Electronic address: 2016034036@hmc.edu.cn.
Abstract
BACKGROUND: Emerging evidence has identified cardiovascular system as a potential target of Bisphenol A (BPA). Although a few studies have revealed the relationship between BPA and the risk of several cardiovascular diseases (CVD) outcomes and CVD risk factors, no published studies have investigated the link between urinary BPA and the risk of stroke. METHODS: Data were derived from the United States National Health and Nutrition Examination Surveys (NHANES), with a representative sample aged ≥20 years (n = 9139) from 2003 to 2014. We performed multivariable logistic regression model to estimate associations between quartiles and natural logarithm transformed urinary BPA concentrations and five specific CVD outcomes and total CVD. RESULTS: In quartile analysis, highest level of urinary BPA was associated with increased prevalence of myocardial infarction (MI) (OR = 1.73, 95% CI = 1.11-2.69) and stroke (OR = 1.61, 95% CI = 1.09-2.36), when compared with those at the lowest quartile. Per unit (μg/g creatinine) increment in ln-transformed BPA concentration was shown to be significantly associated with 19%, 19%, 25%, 29%, 20%, and 16% increased odds ratios of prevalence of congestive heart failure, coronary heart disease (CHD), angina pectoris, MI, stroke and total CVD among total participants, respectively. Similar associations were found in males rather than in females. CONCLUSION: We provided the premier evidence of positive relationship between urinary BPA concentration and stroke in U.S. POPULATION: Urinary BPA levels were also positively correlated with congestive heart failure, CHD, angina pectoris, MI, as well as total CVD. These associations were more evident in males. Well-coordinated and prospective studies are warranted to gain the human effects of BPA on CVD.
BACKGROUND: Emerging evidence has identified cardiovascular system as a potential target of Bisphenol A (BPA). Although a few studies have revealed the relationship between BPA and the risk of several cardiovascular diseases (CVD) outcomes and CVD risk factors, no published studies have investigated the link between urinary BPA and the risk of stroke. METHODS: Data were derived from the United States National Health and Nutrition Examination Surveys (NHANES), with a representative sample aged ≥20 years (n = 9139) from 2003 to 2014. We performed multivariable logistic regression model to estimate associations between quartiles and natural logarithm transformed urinary BPA concentrations and five specific CVD outcomes and total CVD. RESULTS: In quartile analysis, highest level of urinary BPA was associated with increased prevalence of myocardial infarction (MI) (OR = 1.73, 95% CI = 1.11-2.69) and stroke (OR = 1.61, 95% CI = 1.09-2.36), when compared with those at the lowest quartile. Per unit (μg/g creatinine) increment in ln-transformed BPA concentration was shown to be significantly associated with 19%, 19%, 25%, 29%, 20%, and 16% increased odds ratios of prevalence of congestive heart failure, coronary heart disease (CHD), angina pectoris, MI, stroke and total CVD among total participants, respectively. Similar associations were found in males rather than in females. CONCLUSION: We provided the premier evidence of positive relationship between urinary BPA concentration and stroke in U.S. POPULATION: Urinary BPA levels were also positively correlated with congestive heart failure, CHD, angina pectoris, MI, as well as total CVD. These associations were more evident in males. Well-coordinated and prospective studies are warranted to gain the human effects of BPA on CVD.
Authors: Jessica L Levasseur; Stephanie C Hammel; Kate Hoffman; Allison L Phillips; Sharon Zhang; Xiaoyun Ye; Antonia M Calafat; Thomas F Webster; Heather M Stapleton Journal: Environ Int Date: 2020-12-17 Impact factor: 9.621
Authors: Katelyn A Bruno; Logan P Macomb; A Carolina Morales-Lara; Jessica E Mathews; J Augusto Frisancho; Alex L Yang; Damian N Di Florio; Brandy H Edenfield; Emily R Whelan; Gary R Salomon; Anneliese R Hill; Chathuranga C Hewa-Rahinduwage; Ashley J Scott; Henry D Greyner; Frank A Molina; Merci S Greenaway; George M Cooper; DeLisa Fairweather Journal: Int J Mol Sci Date: 2021-08-17 Impact factor: 5.923
Authors: Mikyla A Callaghan; Samuel Alatorre-Hinojosa; Liam T Connors; Radha D Singh; Jennifer A Thompson Journal: Front Pharmacol Date: 2021-02-25 Impact factor: 5.810
Authors: Christopher J Martyniuk; Rubén Martínez; Laia Navarro-Martín; Jorke H Kamstra; Adam Schwendt; Stéphane Reynaud; Lorraine Chalifour Journal: Environ Res Date: 2021-08-19 Impact factor: 6.498
Authors: Sarah Riesbeck; Hannes Petruschke; Ulrike Rolle-Kampczyk; Christian Schori; Christian H Ahrens; Christian Eberlein; Hermann J Heipieper; Martin von Bergen; Nico Jehmlich Journal: Microorganisms Date: 2022-08-09